The work of the Tang Prize winners in biopharmaceutical science has revolutionized the genome editing platform, making it programmable like never before, and could help tackle complicated human diseases, both scholars and Tang Prize Selection Committee members said on Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Insurer proposes 'reasonable' fee for Nvidia HQ site: Taipei official
11/05/2025 03:32 PM - Politics
Pentagon working to expedite Taiwan Harpoon deliveries: DoD nominee
11/05/2025 03:11 PM - Business
Taiwan still in talks with Estonia over opening reciprocal offices
11/05/2025 01:57 PM - Business
Taiwan shares close down 1.42%
11/05/2025 01:47 PM - Science & Tech
Taiwan's 1st Formosat-8 to launch Nov. 11
11/05/2025 01:00 PM